Defective MPDU1 does not promote transfer of Man to N-glycan precursor (GlcNAc)2 (Man)7 (PP-Dol)1 by ALG12

Stable Identifier
R-HSA-4686998
Type
Reaction [transition]
Species
Homo sapiens
Compartment
endoplasmic reticulum membrane, lumenal side of endoplasmic reticulum membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective MPDU1 does not promote transfer of Man to N-glycan precursor (GlcNAc)2 (Man)7 (PP-Dol)1 by ALG12
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Mannose-P-dolichol utilisation defect 1 protein (MPDU1) is required for the efficient utilisation of the mannose donor dolichyl-phospho-mannose (DOLPman) in the synthesis of both lipid-linked oligosaccharides (LLOs) and glycosylphosphatidylinositols by mannosyltransferases ALG3, ALG9 and ALG12. Defects in MPDU1 can cause congenital disorder of glycosylation 1f (MPDU1-CDG, CDG-1f; MIM:609180), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins of varying sizes. CDG type 1 diseases result in a wide phenotypic spectrum, such as poor neurological development, psychomotor retardation, dysmorphic features, hypotonia, coagulation abnormalities and immunodeficiency. In this condition, DOLPman is no longer utilised in transferase reactions extending LLOs, even as substrate levels and transferase enzyme activities appear normal (Anand et al. 2001, Schenk et al. 2001). Point mutations that can cause MPDU1-CDG are G73E, L119P, M1T, L74S as well as the frameshift mutation L171Sfs*42 (Schenk et al. 2001, Kranz et al. 2001).
Literature References
PubMed ID Title Journal Year
11733556 A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If)

Schmid, T, Ray, S, Denecke, J, Kienz, P, Peter-Katalinic, J, Harms, E, Lehrman, MA, Jackowski-Dohrmann, S, Kranz, C, Freeze, HH, Marquardt, T, Sagi, D, Kreissel, G

J. Clin. Invest. 2001
11733564 MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If

Frank, CG, Revel-Vik, S, Raymond, GV, Hurvitz, H, Imbach, T, Aebi, M, Matthijs, G, Schenk, B, Berger, EG, Raas-Rotschild, A, Grubenmann, CE, Hennet, T, Luder, AS, Korn-Lubetzki, I, Jaeken, J

J. Clin. Invest. 2001
11179430 Requirement of the Lec35 gene for all known classes of monosaccharide-P-dolichol-dependent glycosyltransferase reactions in mammals

Ware, FE, Lehrman, MA, Hofsteenge, J, Doucey, MA, Weik, J, Ray, S, Rush, JS, Waechter, CJ, Anand, M

Mol. Biol. Cell 2001
Participants
Input
Participates
as an event of
This event is regulated
Positively by
Regulator
MPDU1 mutants [endoplasmic reticulum membrane] (Homo sapiens)
Normal reaction
ALG12 transfers Man to N-glycan precursor (GlcNAc)2 (Man)7 (PP-Dol)1 (Homo sapiens)
Functional status

Loss of function of MPDU1 mutants [endoplasmic reticulum membrane]

Normal Entity
Disease Entity
Status
Disease
Authored
Jassal, B  (2013-10-15)
Reviewed
Belaya, K  (2014-10-31)
Created
Jassal, B  (2013-10-15)
Cite Us!